Cart
sales@molnova.com
DLinDMA
CAS No. 871258-12-7
DLinDMA( —— )
Catalog No. M24885 CAS No. 871258-12-7
DLinDMA, as a benchmark, is a key stable nucleic acid lipid particleslipid component.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 53 | In Stock |
|
| 50MG | 77 | In Stock |
|
| 100MG | 114 | In Stock |
|
| 200MG | 172 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDLinDMA
-
NoteResearch use only, not for human use.
-
Brief DescriptionDLinDMA, as a benchmark, is a key stable nucleic acid lipid particleslipid component.
-
DescriptionDLinDMA, as a benchmark, is a key stable nucleic acid lipid particleslipid component.
-
In VitroThe structure of DLinDMA can be divided into three main regions: the hydrocarbon chains, the linker and the headgroup.
-
In VivoDLinDMA has virtually indistinguishable blood pharmacokinetic profiles in mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number871258-12-7
-
Formula Weight616.06
-
Molecular FormulaC41H77NO2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 100 mg/mL (162.32 mM);DMSO: < 1 mg/mL (insoluble or slightly soluble)
-
SMILESCCCCC/C=C\C/C=C\CCCCCCCCOCC(OCCCCCCCC/C=C\C/C=C\CCCCC)CN(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Semple SC, et al. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol. 2010 Feb;28(2):172-6.
molnova catalog
related products
-
Norisoboldine
Norisoboldine might be a potential therapeutic agent for rheumatoid arthritis, and it functions through protecting joint destruction as well as regulating the abnormal immune responses.
-
Transportan
Transportan is a 27 amino acid-long peptide containing 12 functional amino acids from the amino terminus of the neuropeptide galanin and mastoparan in the carboxyl terminus, connected via a lysine.
-
Sari 59-801
Sari 59-801 is a novel, orally effective hypoglycemic compound that appears to act largely by stimulation of insulin release. SARI-59-801 was more potent in producing hypoglycemia (ED25 = 47 mg/kg) than their lean littermates (ED25 = 131 mg/kg).
